

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.20936525 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.20936525 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 6.96325403 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.96325403 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.59165308 |
| 6 | tryptophan catabolic process (GO:0006569) | 6.03072865 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 6.03072865 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 6.03072865 |
| 9 | glyoxylate metabolic process (GO:0046487) | 5.94712210 |
| 10 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.80094589 |
| 11 | kynurenine metabolic process (GO:0070189) | 5.79640944 |
| 12 | tryptophan metabolic process (GO:0006568) | 5.73760985 |
| 13 | cullin deneddylation (GO:0010388) | 5.72253563 |
| 14 | bile acid biosynthetic process (GO:0006699) | 5.70949877 |
| 15 | protein deneddylation (GO:0000338) | 5.47018735 |
| 16 | cysteine metabolic process (GO:0006534) | 5.44460392 |
| 17 | urea cycle (GO:0000050) | 5.24389199 |
| 18 | urea metabolic process (GO:0019627) | 5.24389199 |
| 19 | serine family amino acid catabolic process (GO:0009071) | 5.23908617 |
| 20 | complement activation, alternative pathway (GO:0006957) | 5.19342666 |
| 21 | negative regulation of fibrinolysis (GO:0051918) | 5.17466447 |
| 22 | sulfur amino acid catabolic process (GO:0000098) | 5.13471151 |
| 23 | regulation of protein activation cascade (GO:2000257) | 5.04860696 |
| 24 | alpha-linolenic acid metabolic process (GO:0036109) | 5.02390423 |
| 25 | high-density lipoprotein particle remodeling (GO:0034375) | 5.01583272 |
| 26 | regulation of fibrinolysis (GO:0051917) | 4.96377670 |
| 27 | glycine metabolic process (GO:0006544) | 4.93126816 |
| 28 | homocysteine metabolic process (GO:0050667) | 4.87841502 |
| 29 | nitrogen cycle metabolic process (GO:0071941) | 4.85151104 |
| 30 | aromatic amino acid family metabolic process (GO:0009072) | 4.84988797 |
| 31 | proteasome assembly (GO:0043248) | 4.83142737 |
| 32 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.82581686 |
| 33 | protein carboxylation (GO:0018214) | 4.82581686 |
| 34 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.82207305 |
| 35 | lysine catabolic process (GO:0006554) | 4.81972062 |
| 36 | lysine metabolic process (GO:0006553) | 4.81972062 |
| 37 | bile acid metabolic process (GO:0008206) | 4.77131619 |
| 38 | regulation of complement activation (GO:0030449) | 4.74847286 |
| 39 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.67840124 |
| 40 | serine family amino acid metabolic process (GO:0009069) | 4.60203628 |
| 41 | serine family amino acid biosynthetic process (GO:0009070) | 4.60120185 |
| 42 | alpha-amino acid catabolic process (GO:1901606) | 4.59817627 |
| 43 | amino-acid betaine metabolic process (GO:0006577) | 4.57778047 |
| 44 | tyrosine metabolic process (GO:0006570) | 4.57080330 |
| 45 | imidazole-containing compound metabolic process (GO:0052803) | 4.46952366 |
| 46 | aldehyde catabolic process (GO:0046185) | 4.43694880 |
| 47 | regulation of cholesterol esterification (GO:0010872) | 4.41596395 |
| 48 | regulation of triglyceride catabolic process (GO:0010896) | 4.37818611 |
| 49 | negative regulation of cholesterol transport (GO:0032375) | 4.29231241 |
| 50 | negative regulation of sterol transport (GO:0032372) | 4.29231241 |
| 51 | amine catabolic process (GO:0009310) | 4.28346119 |
| 52 | cellular biogenic amine catabolic process (GO:0042402) | 4.28346119 |
| 53 | indolalkylamine metabolic process (GO:0006586) | 4.27154540 |
| 54 | cellular ketone body metabolic process (GO:0046950) | 4.27135199 |
| 55 | reverse cholesterol transport (GO:0043691) | 4.26556821 |
| 56 | protein-lipid complex remodeling (GO:0034368) | 4.25294264 |
| 57 | macromolecular complex remodeling (GO:0034367) | 4.25294264 |
| 58 | plasma lipoprotein particle remodeling (GO:0034369) | 4.25294264 |
| 59 | acylglycerol homeostasis (GO:0055090) | 4.24134552 |
| 60 | triglyceride homeostasis (GO:0070328) | 4.24134552 |
| 61 | cellular amino acid catabolic process (GO:0009063) | 4.23390126 |
| 62 | ATP synthesis coupled proton transport (GO:0015986) | 4.17015207 |
| 63 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.17015207 |
| 64 | ethanol oxidation (GO:0006069) | 4.16677684 |
| 65 | bile acid and bile salt transport (GO:0015721) | 4.11468293 |
| 66 | regulation of mitochondrial translation (GO:0070129) | 4.11037740 |
| 67 | coenzyme catabolic process (GO:0009109) | 4.10144927 |
| 68 | phospholipid efflux (GO:0033700) | 4.02506352 |
| 69 | cellular glucuronidation (GO:0052695) | 4.02447969 |
| 70 | benzene-containing compound metabolic process (GO:0042537) | 3.99300976 |
| 71 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.90788572 |
| 72 | plasma lipoprotein particle clearance (GO:0034381) | 3.90660211 |
| 73 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.88102776 |
| 74 | branched-chain amino acid catabolic process (GO:0009083) | 3.87821304 |
| 75 | respiratory chain complex IV assembly (GO:0008535) | 3.87055103 |
| 76 | glutamate metabolic process (GO:0006536) | 3.85886159 |
| 77 | arginine metabolic process (GO:0006525) | 3.84507115 |
| 78 | cellular modified amino acid catabolic process (GO:0042219) | 3.79044132 |
| 79 | drug catabolic process (GO:0042737) | 3.75865492 |
| 80 | blood coagulation, intrinsic pathway (GO:0007597) | 3.74527311 |
| 81 | urate metabolic process (GO:0046415) | 3.73620705 |
| 82 | organic acid catabolic process (GO:0016054) | 3.72832441 |
| 83 | carboxylic acid catabolic process (GO:0046395) | 3.72832441 |
| 84 | NAD biosynthetic process (GO:0009435) | 3.72694378 |
| 85 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.70133073 |
| 86 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.70133073 |
| 87 | ketone body metabolic process (GO:1902224) | 3.68011157 |
| 88 | acetyl-CoA metabolic process (GO:0006084) | 3.67284502 |
| 89 | protein complex biogenesis (GO:0070271) | 3.66301086 |
| 90 | cholesterol efflux (GO:0033344) | 3.66249653 |
| 91 | respiratory electron transport chain (GO:0022904) | 3.64999129 |
| 92 | short-chain fatty acid metabolic process (GO:0046459) | 3.64636764 |
| 93 | cofactor catabolic process (GO:0051187) | 3.64422609 |
| 94 | complement activation, classical pathway (GO:0006958) | 3.63384674 |
| 95 | fibrinolysis (GO:0042730) | 3.63171989 |
| 96 | electron transport chain (GO:0022900) | 3.63159386 |
| 97 | response to nitrosative stress (GO:0051409) | 3.61987307 |
| 98 | low-density lipoprotein particle remodeling (GO:0034374) | 3.61426417 |
| 99 | complement activation (GO:0006956) | 3.60712795 |
| 100 | glucuronate metabolic process (GO:0019585) | 3.59707874 |
| 101 | uronic acid metabolic process (GO:0006063) | 3.59707874 |
| 102 | L-serine metabolic process (GO:0006563) | 3.57115484 |
| 103 | protein activation cascade (GO:0072376) | 3.53371815 |
| 104 | cytochrome complex assembly (GO:0017004) | 3.53101668 |
| 105 | plasma lipoprotein particle assembly (GO:0034377) | 3.51751190 |
| 106 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.51279268 |
| 107 | drug transmembrane transport (GO:0006855) | 3.51029993 |
| 108 | aspartate family amino acid catabolic process (GO:0009068) | 3.46355515 |
| 109 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.46353650 |
| 110 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.46353650 |
| 111 | cytolysis (GO:0019835) | 3.45213782 |
| 112 | cholesterol homeostasis (GO:0042632) | 3.42785814 |
| 113 | drug metabolic process (GO:0017144) | 3.42384393 |
| 114 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.41808543 |
| 115 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.41785166 |
| 116 | regulation of bile acid biosynthetic process (GO:0070857) | 3.39759510 |
| 117 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.39671058 |
| 118 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.37696861 |
| 119 | NADH dehydrogenase complex assembly (GO:0010257) | 3.37696861 |
| 120 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.37696861 |
| 121 | rRNA modification (GO:0000154) | 3.33609826 |
| 122 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.25602192 |
| 123 | branched-chain amino acid metabolic process (GO:0009081) | 3.15463879 |
| 124 | chaperone-mediated protein transport (GO:0072321) | 3.15350171 |
| 125 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.13685155 |
| 126 | L-methionine salvage (GO:0071267) | 3.09869470 |
| 127 | L-methionine biosynthetic process (GO:0071265) | 3.09869470 |
| 128 | amino acid salvage (GO:0043102) | 3.09869470 |
| 129 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.04436920 |
| 130 | ribosomal large subunit biogenesis (GO:0042273) | 3.03751378 |
| 131 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.00831992 |
| 132 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.00831992 |
| 133 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.00831992 |
| 134 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.96108281 |
| 135 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.96108281 |
| 136 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.95252240 |
| 137 | oxidative phosphorylation (GO:0006119) | 2.95200772 |
| 138 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.94014296 |
| 139 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.92167456 |
| 140 | termination of RNA polymerase III transcription (GO:0006386) | 2.92167456 |
| 141 | oxidative demethylation (GO:0070989) | 2.91525919 |
| 142 | methionine biosynthetic process (GO:0009086) | 2.89625201 |
| 143 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.89043453 |
| 144 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.89043453 |
| 145 | ribosomal small subunit assembly (GO:0000028) | 2.88092422 |
| 146 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.88040237 |
| 147 | negative regulation of ligase activity (GO:0051352) | 2.86413025 |
| 148 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.86413025 |
| 149 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.85314861 |
| 150 | pseudouridine synthesis (GO:0001522) | 2.84024543 |
| 151 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.83943491 |
| 152 | glutathione derivative metabolic process (GO:1901685) | 2.81115289 |
| 153 | glutathione derivative biosynthetic process (GO:1901687) | 2.81115289 |
| 154 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.80199806 |
| 155 | magnesium ion transport (GO:0015693) | 2.80119163 |
| 156 | rRNA methylation (GO:0031167) | 2.76594859 |
| 157 | base-excision repair, AP site formation (GO:0006285) | 2.76489166 |
| 158 | DNA deamination (GO:0045006) | 2.74992497 |
| 159 | xenobiotic catabolic process (GO:0042178) | 2.74347043 |
| 160 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.73990029 |
| 161 | maturation of SSU-rRNA (GO:0030490) | 2.73490375 |
| 162 | protein K6-linked ubiquitination (GO:0085020) | 2.72132712 |
| 163 | S-adenosylmethionine metabolic process (GO:0046500) | 2.71952373 |
| 164 | peptidyl-histidine modification (GO:0018202) | 2.71671852 |
| 165 | adenosine metabolic process (GO:0046085) | 2.71549806 |
| 166 | daunorubicin metabolic process (GO:0044597) | 2.70396192 |
| 167 | polyketide metabolic process (GO:0030638) | 2.70396192 |
| 168 | doxorubicin metabolic process (GO:0044598) | 2.70396192 |
| 169 | methionine metabolic process (GO:0006555) | 2.69507411 |
| 170 | translation (GO:0006412) | 2.69023556 |
| 171 | tRNA modification (GO:0006400) | 2.68803019 |
| 172 | exogenous drug catabolic process (GO:0042738) | 2.68679840 |
| 173 | tRNA processing (GO:0008033) | 2.68654970 |
| 174 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.67986184 |
| 175 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.67305277 |
| 176 | mitochondrial RNA metabolic process (GO:0000959) | 2.66681843 |
| 177 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.65778723 |
| 178 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.63805500 |
| 179 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.63805500 |
| 180 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.60107456 |
| 181 | quinone metabolic process (GO:1901661) | 2.58539661 |
| 182 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.57904728 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.14088330 |
| 2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.56625728 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.22854361 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.24352692 |
| 5 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.09041843 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.64502201 |
| 7 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.18244621 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.12053455 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.95718039 |
| 10 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.80597360 |
| 11 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.36408458 |
| 12 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.32928527 |
| 13 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.21656969 |
| 14 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.4950847 |
| 15 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.99326145 |
| 16 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.97641480 |
| 17 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.94539621 |
| 18 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.83447688 |
| 19 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.80884037 |
| 20 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.79948001 |
| 21 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.77511258 |
| 22 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.72666730 |
| 23 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.69367987 |
| 24 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.60203792 |
| 25 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.53120362 |
| 26 | GATA1_22025678_ChIP-Seq_K562_Human | 1.45003569 |
| 27 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.41896887 |
| 28 | VDR_22108803_ChIP-Seq_LS180_Human | 1.39738213 |
| 29 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.39163897 |
| 30 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.37560109 |
| 31 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.34374479 |
| 32 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.32618511 |
| 33 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.29812892 |
| 34 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.29117416 |
| 35 | FUS_26573619_Chip-Seq_HEK293_Human | 1.28477462 |
| 36 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.27675507 |
| 37 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.26645647 |
| 38 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.26368680 |
| 39 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.25613405 |
| 40 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.24426857 |
| 41 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.23519466 |
| 42 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.22628607 |
| 43 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.22128725 |
| 44 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.21880098 |
| 45 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.21748358 |
| 46 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.21488207 |
| 47 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.21488207 |
| 48 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.19488694 |
| 49 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.18024964 |
| 50 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.16660223 |
| 51 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.16512999 |
| 52 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.14382094 |
| 53 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.14022866 |
| 54 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.13744706 |
| 55 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.12223946 |
| 56 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.11490253 |
| 57 | EWS_26573619_Chip-Seq_HEK293_Human | 1.10271313 |
| 58 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.09067519 |
| 59 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.08753337 |
| 60 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.07185197 |
| 61 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.06540976 |
| 62 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.04984415 |
| 63 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.04641262 |
| 64 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.03146780 |
| 65 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.01247277 |
| 66 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.00340845 |
| 67 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.99976234 |
| 68 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.99004156 |
| 69 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.97814807 |
| 70 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.97171382 |
| 71 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.97119222 |
| 72 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.96766537 |
| 73 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.95330435 |
| 74 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.94913787 |
| 75 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.94913787 |
| 76 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.94673164 |
| 77 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92906174 |
| 78 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.92883318 |
| 79 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.92448900 |
| 80 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.91915632 |
| 81 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.91106070 |
| 82 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.90491203 |
| 83 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.89620036 |
| 84 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.89531722 |
| 85 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.88019723 |
| 86 | NCOR_22424771_ChIP-Seq_293T_Human | 0.87708987 |
| 87 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.86859683 |
| 88 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.86704392 |
| 89 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.85920841 |
| 90 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.85370382 |
| 91 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.85361072 |
| 92 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.84796508 |
| 93 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.83379190 |
| 94 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.82738754 |
| 95 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.81361462 |
| 96 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.81055113 |
| 97 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.81026344 |
| 98 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.80879211 |
| 99 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.80348034 |
| 100 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.78938667 |
| 101 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.78908189 |
| 102 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.78520447 |
| 103 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.78475008 |
| 104 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.78371264 |
| 105 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.78297387 |
| 106 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.77712105 |
| 107 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.77417975 |
| 108 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.77142629 |
| 109 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.75889644 |
| 110 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.75625932 |
| 111 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.75505845 |
| 112 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.75384589 |
| 113 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.74173814 |
| 114 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.73525794 |
| 115 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.72601646 |
| 116 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.72528825 |
| 117 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.71952268 |
| 118 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.70176217 |
| 119 | * OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.69091841 |
| 120 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.68538870 |
| 121 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.68324035 |
| 122 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.67633311 |
| 123 | * TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.67557913 |
| 124 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.66529822 |
| 125 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.66302491 |
| 126 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.65393545 |
| 127 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.64893914 |
| 128 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.64893438 |
| 129 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.64689718 |
| 130 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.62454088 |
| 131 | * NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.62163636 |
| 132 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.60806231 |
| 133 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.60662759 |
| 134 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.60625304 |
| 135 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.60518846 |
| 136 | AR_20517297_ChIP-Seq_VCAP_Human | 0.60421862 |
| 137 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.60328818 |
| 138 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.60326020 |
| 139 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.59344214 |
| 140 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.58373220 |
| 141 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.56388609 |
| 142 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.54579165 |
| 143 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.54019669 |
| 144 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.53824774 |
| 145 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.52343247 |
| 146 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.52143482 |
| 147 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.51527807 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.95049210 |
| 2 | MP0005360_urolithiasis | 7.33570607 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.13080868 |
| 4 | MP0005365_abnormal_bile_salt | 5.90235678 |
| 5 | MP0003806_abnormal_nucleotide_metabolis | 5.04637063 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 4.88345981 |
| 7 | MP0003252_abnormal_bile_duct | 3.66827118 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.21546583 |
| 9 | MP0002837_dystrophic_cardiac_calcinosis | 3.07704548 |
| 10 | MP0003195_calcinosis | 3.03551946 |
| 11 | MP0008058_abnormal_DNA_repair | 2.85085012 |
| 12 | MP0005332_abnormal_amino_acid | 2.82068692 |
| 13 | MP0009840_abnormal_foam_cell | 2.80746271 |
| 14 | MP0000372_irregular_coat_pigmentation | 2.65893723 |
| 15 | MP0005083_abnormal_biliary_tract | 2.64487994 |
| 16 | MP0001666_abnormal_nutrient_absorption | 2.39766082 |
| 17 | MP0009697_abnormal_copulation | 2.25884945 |
| 18 | MP0004019_abnormal_vitamin_homeostasis | 2.21208021 |
| 19 | MP0003191_abnormal_cellular_cholesterol | 2.03186021 |
| 20 | MP0000609_abnormal_liver_physiology | 2.01669321 |
| 21 | MP0001764_abnormal_homeostasis | 1.95225232 |
| 22 | MP0003186_abnormal_redox_activity | 1.94448681 |
| 23 | MP0005319_abnormal_enzyme/_coenzyme | 1.89095882 |
| 24 | MP0002118_abnormal_lipid_homeostasis | 1.85195472 |
| 25 | MP0002938_white_spotting | 1.82365617 |
| 26 | MP0003786_premature_aging | 1.79530648 |
| 27 | MP0002138_abnormal_hepatobiliary_system | 1.77044137 |
| 28 | MP0005646_abnormal_pituitary_gland | 1.66681405 |
| 29 | MP0003868_abnormal_feces_composition | 1.64048715 |
| 30 | MP0010094_abnormal_chromosome_stability | 1.57367474 |
| 31 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.56587347 |
| 32 | MP0006072_abnormal_retinal_apoptosis | 1.56285879 |
| 33 | MP0002160_abnormal_reproductive_system | 1.53337586 |
| 34 | MP0005451_abnormal_body_composition | 1.52767354 |
| 35 | MP0009780_abnormal_chondrocyte_physiolo | 1.51773902 |
| 36 | MP0003950_abnormal_plasma_membrane | 1.41813690 |
| 37 | MP0003011_delayed_dark_adaptation | 1.36832020 |
| 38 | MP0010386_abnormal_urinary_bladder | 1.33193876 |
| 39 | MP0009643_abnormal_urine_homeostasis | 1.31981466 |
| 40 | MP0008057_abnormal_DNA_replication | 1.29430626 |
| 41 | MP0006036_abnormal_mitochondrial_physio | 1.28466214 |
| 42 | MP0003646_muscle_fatigue | 1.26565967 |
| 43 | MP0002102_abnormal_ear_morphology | 1.26324658 |
| 44 | MP0003656_abnormal_erythrocyte_physiolo | 1.26267383 |
| 45 | MP0000598_abnormal_liver_morphology | 1.24961697 |
| 46 | MP0005379_endocrine/exocrine_gland_phen | 1.24043336 |
| 47 | MP0005647_abnormal_sex_gland | 1.20601194 |
| 48 | MP0005410_abnormal_fertilization | 1.20306654 |
| 49 | MP0005551_abnormal_eye_electrophysiolog | 1.20067899 |
| 50 | MP0005174_abnormal_tail_pigmentation | 1.19619194 |
| 51 | MP0000427_abnormal_hair_cycle | 1.19356308 |
| 52 | MP0004043_abnormal_pH_regulation | 1.15429094 |
| 53 | MP0000358_abnormal_cell_content/ | 1.08770442 |
| 54 | MP0002163_abnormal_gland_morphology | 1.07042632 |
| 55 | MP0009763_increased_sensitivity_to | 1.06795879 |
| 56 | MP0001986_abnormal_taste_sensitivity | 1.05688851 |
| 57 | MP0003718_maternal_effect | 1.04482869 |
| 58 | MP0005408_hypopigmentation | 1.04478627 |
| 59 | MP0000013_abnormal_adipose_tissue | 1.02777611 |
| 60 | MP0005636_abnormal_mineral_homeostasis | 1.02380178 |
| 61 | MP0005645_abnormal_hypothalamus_physiol | 1.01367471 |
| 62 | MP0005330_cardiomyopathy | 0.98995196 |
| 63 | MP0009764_decreased_sensitivity_to | 0.98386717 |
| 64 | MP0008007_abnormal_cellular_replicative | 0.97880197 |
| 65 | MP0010368_abnormal_lymphatic_system | 0.97576647 |
| 66 | MP0005389_reproductive_system_phenotype | 0.97236100 |
| 67 | MP0008469_abnormal_protein_level | 0.93417847 |
| 68 | MP0005253_abnormal_eye_physiology | 0.93366615 |
| 69 | MP0006035_abnormal_mitochondrial_morpho | 0.93174136 |
| 70 | MP0005376_homeostasis/metabolism_phenot | 0.91371560 |
| 71 | MP0005266_abnormal_metabolism | 0.90579235 |
| 72 | MP0002166_altered_tumor_susceptibility | 0.88955354 |
| 73 | MP0005084_abnormal_gallbladder_morpholo | 0.88899272 |
| 74 | MP0000371_diluted_coat_color | 0.88445648 |
| 75 | MP0003077_abnormal_cell_cycle | 0.88387572 |
| 76 | MP0009765_abnormal_xenobiotic_induced | 0.84392809 |
| 77 | MP0009642_abnormal_blood_homeostasis | 0.84183654 |
| 78 | MP0001905_abnormal_dopamine_level | 0.84087519 |
| 79 | MP0004147_increased_porphyrin_level | 0.84005560 |
| 80 | MP0002638_abnormal_pupillary_reflex | 0.83841867 |
| 81 | MP0002095_abnormal_skin_pigmentation | 0.81721096 |
| 82 | MP0000647_abnormal_sebaceous_gland | 0.81389852 |
| 83 | MP0003705_abnormal_hypodermis_morpholog | 0.80319206 |
| 84 | MP0002006_tumorigenesis | 0.79970041 |
| 85 | MP0005220_abnormal_exocrine_pancreas | 0.78824062 |
| 86 | MP0008775_abnormal_heart_ventricle | 0.78226540 |
| 87 | MP0005171_absent_coat_pigmentation | 0.78001904 |
| 88 | MP0002396_abnormal_hematopoietic_system | 0.77362818 |
| 89 | MP0009053_abnormal_anal_canal | 0.76942587 |
| 90 | MP0005670_abnormal_white_adipose | 0.76668566 |
| 91 | MP0000383_abnormal_hair_follicle | 0.76067449 |
| 92 | MP0002277_abnormal_respiratory_mucosa | 0.75130160 |
| 93 | MP0002132_abnormal_respiratory_system | 0.72028294 |
| 94 | MP0004215_abnormal_myocardial_fiber | 0.70370716 |
| 95 | MP0002148_abnormal_hypersensitivity_rea | 0.69305010 |
| 96 | MP0002736_abnormal_nociception_after | 0.68124854 |
| 97 | MP0003111_abnormal_nucleus_morphology | 0.67732369 |
| 98 | MP0002254_reproductive_system_inflammat | 0.66707420 |
| 99 | MP0003136_yellow_coat_color | 0.66364162 |
| 100 | MP0005395_other_phenotype | 0.65898456 |
| 101 | MP0001661_extended_life_span | 0.65340385 |
| 102 | MP0000749_muscle_degeneration | 0.64615002 |
| 103 | MP0001929_abnormal_gametogenesis | 0.62961502 |
| 104 | MP0008877_abnormal_DNA_methylation | 0.62650865 |
| 105 | MP0005165_increased_susceptibility_to | 0.61876953 |
| 106 | MP0002876_abnormal_thyroid_physiology | 0.61685091 |
| 107 | MP0001756_abnormal_urination | 0.61334789 |
| 108 | MP0001853_heart_inflammation | 0.58376695 |
| 109 | MP0002078_abnormal_glucose_homeostasis | 0.58052208 |
| 110 | MP0000604_amyloidosis | 0.57852805 |
| 111 | MP0002136_abnormal_kidney_physiology | 0.56102640 |
| 112 | MP0003724_increased_susceptibility_to | 0.54601149 |
| 113 | MP0004782_abnormal_surfactant_physiolog | 0.54529331 |
| 114 | MP0000639_abnormal_adrenal_gland | 0.53417696 |
| 115 | MP0002971_abnormal_brown_adipose | 0.53134844 |
| 116 | MP0005334_abnormal_fat_pad | 0.51914789 |
| 117 | MP0008873_increased_physiological_sensi | 0.50373041 |
| 118 | MP0003638_abnormal_response/metabolism_ | 0.46907087 |
| 119 | MP0005464_abnormal_platelet_physiology | 0.46656587 |
| 120 | MP0009379_abnormal_foot_pigmentation | 0.42843122 |
| 121 | MP0009672_abnormal_birth_weight | 0.41414158 |
| 122 | MP0001243_abnormal_dermal_layer | 0.40395872 |
| 123 | MP0003436_decreased_susceptibility_to | 0.39769598 |
| 124 | MP0005535_abnormal_body_temperature | 0.37919847 |
| 125 | MP0001119_abnormal_female_reproductive | 0.37832515 |
| 126 | MP0005248_abnormal_Harderian_gland | 0.37284762 |
| 127 | MP0005075_abnormal_melanosome_morpholog | 0.35364258 |
| 128 | MP0005448_abnormal_energy_balance | 0.35049380 |
| 129 | MP0002135_abnormal_kidney_morphology | 0.34004203 |
| 130 | MP0001845_abnormal_inflammatory_respons | 0.32461628 |
| 131 | MP0002928_abnormal_bile_duct | 0.32188302 |
| 132 | MP0003699_abnormal_female_reproductive | 0.32051983 |
| 133 | MP0005023_abnormal_wound_healing | 0.31754461 |
| 134 | MP0008872_abnormal_physiological_respon | 0.31681038 |
| 135 | MP0002060_abnormal_skin_morphology | 0.31606856 |
| 136 | MP0003693_abnormal_embryo_hatching | 0.31194040 |
| 137 | MP0002970_abnormal_white_adipose | 0.29418068 |
| 138 | MP0003953_abnormal_hormone_level | 0.28189639 |
| 139 | MP0004381_abnormal_hair_follicle | 0.27534012 |
| 140 | MP0002796_impaired_skin_barrier | 0.26675858 |
| 141 | MP0001915_intracranial_hemorrhage | 0.26614039 |
| 142 | MP0006082_CNS_inflammation | 0.25860259 |
| 143 | MP0001881_abnormal_mammary_gland | 0.25785227 |
| 144 | MP0000249_abnormal_blood_vessel | 0.24802449 |
| 145 | MP0004130_abnormal_muscle_cell | 0.24631195 |
| 146 | MP0002269_muscular_atrophy | 0.24443832 |
| 147 | MP0009785_altered_susceptibility_to | 0.23196182 |
| 148 | MP0004957_abnormal_blastocyst_morpholog | 0.22956830 |
| 149 | MP0009115_abnormal_fat_cell | 0.22638135 |
| 150 | MP0000230_abnormal_systemic_arterial | 0.22081788 |
| 151 | MP0005666_abnormal_adipose_tissue | 0.21802968 |
| 152 | MP0005166_decreased_susceptibility_to | 0.21469834 |
| 153 | MP0002168_other_aberrant_phenotype | 0.19765200 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 7.03001277 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.96968386 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.51288802 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.41694720 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 6.28939638 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 5.93765660 |
| 7 | Xanthomatosis (HP:0000991) | 5.64071472 |
| 8 | Complement deficiency (HP:0004431) | 5.13981674 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 4.99674999 |
| 10 | Hyperammonemia (HP:0001987) | 4.72398136 |
| 11 | Hyperglycinemia (HP:0002154) | 4.69903312 |
| 12 | Hypolipoproteinemia (HP:0010981) | 4.45138706 |
| 13 | Joint hemorrhage (HP:0005261) | 4.40600973 |
| 14 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.37522542 |
| 15 | Abnormality of methionine metabolism (HP:0010901) | 4.33692003 |
| 16 | Hyperglycinuria (HP:0003108) | 4.32114164 |
| 17 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.25924188 |
| 18 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.22370924 |
| 19 | Abnormality of glycine metabolism (HP:0010895) | 4.22370924 |
| 20 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.21134838 |
| 21 | Acute necrotizing encephalopathy (HP:0006965) | 4.17074017 |
| 22 | Acute encephalopathy (HP:0006846) | 4.11342594 |
| 23 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.09804617 |
| 24 | Ketosis (HP:0001946) | 4.06491071 |
| 25 | Fat malabsorption (HP:0002630) | 4.05237516 |
| 26 | Mitochondrial inheritance (HP:0001427) | 4.03906508 |
| 27 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.03808078 |
| 28 | Increased CSF lactate (HP:0002490) | 4.03381257 |
| 29 | Epidermoid cyst (HP:0200040) | 3.97600671 |
| 30 | Abnormality of the common coagulation pathway (HP:0010990) | 3.92422388 |
| 31 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.91429118 |
| 32 | Abnormality of complement system (HP:0005339) | 3.83424777 |
| 33 | Hypoglycemic coma (HP:0001325) | 3.83273057 |
| 34 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.72167973 |
| 35 | Hepatocellular necrosis (HP:0001404) | 3.69283019 |
| 36 | Hypoalphalipoproteinemia (HP:0003233) | 3.59147619 |
| 37 | Progressive macrocephaly (HP:0004481) | 3.56136603 |
| 38 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.54682599 |
| 39 | Delayed CNS myelination (HP:0002188) | 3.51492923 |
| 40 | Lipid accumulation in hepatocytes (HP:0006561) | 3.47882445 |
| 41 | Increased hepatocellular lipid droplets (HP:0006565) | 3.46874662 |
| 42 | Abnormality of serum amino acid levels (HP:0003112) | 3.40576773 |
| 43 | Abnormality of the intrinsic pathway (HP:0010989) | 3.34488161 |
| 44 | Conjugated hyperbilirubinemia (HP:0002908) | 3.31362268 |
| 45 | Hypercholesterolemia (HP:0003124) | 3.29270741 |
| 46 | Hyperbilirubinemia (HP:0002904) | 3.29001580 |
| 47 | Abnormality of nucleobase metabolism (HP:0010932) | 3.26751759 |
| 48 | Steatorrhea (HP:0002570) | 3.24992592 |
| 49 | Increased serum lactate (HP:0002151) | 3.08186473 |
| 50 | Renal Fanconi syndrome (HP:0001994) | 3.04037957 |
| 51 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.03050149 |
| 52 | Dicarboxylic aciduria (HP:0003215) | 3.03050149 |
| 53 | Methylmalonic acidemia (HP:0002912) | 3.00772394 |
| 54 | Lactic acidosis (HP:0003128) | 3.00499780 |
| 55 | Pancreatic cysts (HP:0001737) | 2.98703088 |
| 56 | Lethargy (HP:0001254) | 2.97790569 |
| 57 | Systemic lupus erythematosus (HP:0002725) | 2.93369782 |
| 58 | Hepatocellular carcinoma (HP:0001402) | 2.91807226 |
| 59 | Hyperalaninemia (HP:0003348) | 2.91038038 |
| 60 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.91038038 |
| 61 | Abnormality of alanine metabolism (HP:0010916) | 2.91038038 |
| 62 | Type I transferrin isoform profile (HP:0003642) | 2.90465107 |
| 63 | Methylmalonic aciduria (HP:0012120) | 2.87471755 |
| 64 | Cerebral edema (HP:0002181) | 2.86797347 |
| 65 | Metabolic acidosis (HP:0001942) | 2.86448777 |
| 66 | Ketoacidosis (HP:0001993) | 2.83712745 |
| 67 | Abnormality of purine metabolism (HP:0004352) | 2.71366368 |
| 68 | Reduced antithrombin III activity (HP:0001976) | 2.71055990 |
| 69 | Respiratory failure (HP:0002878) | 2.66859091 |
| 70 | Generalized aminoaciduria (HP:0002909) | 2.64815397 |
| 71 | Hypochromic microcytic anemia (HP:0004840) | 2.61454377 |
| 72 | Spontaneous abortion (HP:0005268) | 2.59229600 |
| 73 | Spastic diplegia (HP:0001264) | 2.58342552 |
| 74 | 3-Methylglutaconic aciduria (HP:0003535) | 2.57846345 |
| 75 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.56898992 |
| 76 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.56898992 |
| 77 | Vascular calcification (HP:0004934) | 2.56703906 |
| 78 | Gout (HP:0001997) | 2.53549502 |
| 79 | CNS demyelination (HP:0007305) | 2.53299408 |
| 80 | Increased intramyocellular lipid droplets (HP:0012240) | 2.50759592 |
| 81 | Molar tooth sign on MRI (HP:0002419) | 2.50480815 |
| 82 | Abnormality of midbrain morphology (HP:0002418) | 2.50480815 |
| 83 | Pancreatic fibrosis (HP:0100732) | 2.50430904 |
| 84 | Myocardial infarction (HP:0001658) | 2.48760612 |
| 85 | Abnormal protein glycosylation (HP:0012346) | 2.48662099 |
| 86 | Abnormal glycosylation (HP:0012345) | 2.48662099 |
| 87 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.48662099 |
| 88 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.48662099 |
| 89 | Abnormality of the renal cortex (HP:0011035) | 2.45691961 |
| 90 | Glomerulonephritis (HP:0000099) | 2.42236018 |
| 91 | Skin nodule (HP:0200036) | 2.40361777 |
| 92 | Abnormal number of erythroid precursors (HP:0012131) | 2.34368004 |
| 93 | Malnutrition (HP:0004395) | 2.31096938 |
| 94 | Proximal tubulopathy (HP:0000114) | 2.29072570 |
| 95 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.28854881 |
| 96 | Vomiting (HP:0002013) | 2.24682392 |
| 97 | Nausea (HP:0002018) | 2.24375688 |
| 98 | Acanthocytosis (HP:0001927) | 2.24271173 |
| 99 | Cardiovascular calcification (HP:0011915) | 2.23669788 |
| 100 | Increased muscle lipid content (HP:0009058) | 2.23502656 |
| 101 | Neonatal onset (HP:0003623) | 2.23379956 |
| 102 | Exercise intolerance (HP:0003546) | 2.22456546 |
| 103 | Renal cortical cysts (HP:0000803) | 2.21955916 |
| 104 | Irritability (HP:0000737) | 2.21253530 |
| 105 | Brushfield spots (HP:0001088) | 2.20234025 |
| 106 | Opisthotonus (HP:0002179) | 2.20090407 |
| 107 | Glycosuria (HP:0003076) | 2.18916932 |
| 108 | Abnormality of urine glucose concentration (HP:0011016) | 2.18916932 |
| 109 | Nephronophthisis (HP:0000090) | 2.18576031 |
| 110 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.17987438 |
| 111 | Optic disc pallor (HP:0000543) | 2.14125562 |
| 112 | Pancreatitis (HP:0001733) | 2.11373289 |
| 113 | Abnormal gallbladder morphology (HP:0012437) | 2.09984306 |
| 114 | Abnormal gallbladder physiology (HP:0012438) | 2.09764911 |
| 115 | Cholecystitis (HP:0001082) | 2.09764911 |
| 116 | Hypoglycemic seizures (HP:0002173) | 2.08775434 |
| 117 | Conjunctival hamartoma (HP:0100780) | 2.08608024 |
| 118 | Abnormal biliary tract physiology (HP:0012439) | 2.07573957 |
| 119 | Bile duct proliferation (HP:0001408) | 2.07573957 |
| 120 | Cholelithiasis (HP:0001081) | 2.06764285 |
| 121 | Enlarged kidneys (HP:0000105) | 2.03641241 |
| 122 | Rickets (HP:0002748) | 2.02780110 |
| 123 | Hepatic necrosis (HP:0002605) | 2.02054765 |
| 124 | Abnormality of vitamin B metabolism (HP:0004340) | 2.01798175 |
| 125 | True hermaphroditism (HP:0010459) | 2.00577008 |
| 126 | Esophageal varix (HP:0002040) | 2.00390946 |
| 127 | Chronic hepatic failure (HP:0100626) | 2.00020779 |
| 128 | Abnormality of macular pigmentation (HP:0008002) | 1.98005038 |
| 129 | Abnormal cartilage morphology (HP:0002763) | 1.97800535 |
| 130 | Thrombophlebitis (HP:0004418) | 1.95602515 |
| 131 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.94907481 |
| 132 | Exertional dyspnea (HP:0002875) | 1.94551250 |
| 133 | Congenital, generalized hypertrichosis (HP:0004540) | 1.94473244 |
| 134 | Abnormality of iron homeostasis (HP:0011031) | 1.92679682 |
| 135 | Abnormality of the renal medulla (HP:0100957) | 1.92348731 |
| 136 | Elevated hepatic transaminases (HP:0002910) | 1.92180621 |
| 137 | Macrocytic anemia (HP:0001972) | 1.91563730 |
| 138 | Late onset (HP:0003584) | 1.90421017 |
| 139 | Abnormality of renal resorption (HP:0011038) | 1.90375966 |
| 140 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.89836323 |
| 141 | Gingival bleeding (HP:0000225) | 1.89535948 |
| 142 | Alkalosis (HP:0001948) | 1.89149989 |
| 143 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.89124058 |
| 144 | Hypophosphatemic rickets (HP:0004912) | 1.89005318 |
| 145 | Mitral stenosis (HP:0001718) | 1.88099824 |
| 146 | Congenital stationary night blindness (HP:0007642) | 1.84859127 |
| 147 | Menorrhagia (HP:0000132) | 1.84710018 |
| 148 | Abnormality of vitamin metabolism (HP:0100508) | 1.84668969 |
| 149 | Increased purine levels (HP:0004368) | 1.84201347 |
| 150 | Hyperuricemia (HP:0002149) | 1.84201347 |
| 151 | Sensorimotor neuropathy (HP:0007141) | 1.83868428 |
| 152 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.83412836 |
| 153 | Poikilocytosis (HP:0004447) | 1.79811444 |
| 154 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.79317632 |
| 155 | Furrowed tongue (HP:0000221) | 1.78930954 |
| 156 | Increased serum pyruvate (HP:0003542) | 1.78688657 |
| 157 | Abnormality of glycolysis (HP:0004366) | 1.78688657 |
| 158 | Medial flaring of the eyebrow (HP:0010747) | 1.78210066 |
| 159 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.76154071 |
| 160 | Tubular atrophy (HP:0000092) | 1.75057365 |
| 161 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.74580727 |
| 162 | Colon cancer (HP:0003003) | 1.73418593 |
| 163 | Respiratory difficulties (HP:0002880) | 1.73378922 |
| 164 | Palpitations (HP:0001962) | 1.73113633 |
| 165 | Leukodystrophy (HP:0002415) | 1.71974219 |
| 166 | Hypothermia (HP:0002045) | 1.70160335 |
| 167 | Abnormal drinking behavior (HP:0030082) | 1.69876490 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.49387830 |
| 2 | VRK2 | 5.04157478 |
| 3 | NUAK1 | 3.31916822 |
| 4 | FGFR4 | 2.88110444 |
| 5 | ERN1 | 2.80979556 |
| 6 | EIF2AK1 | 2.69827500 |
| 7 | MST4 | 2.67657511 |
| 8 | SIK1 | 2.58992066 |
| 9 | STK16 | 2.51375139 |
| 10 | FLT3 | 2.49581100 |
| 11 | ERBB4 | 2.49436968 |
| 12 | PDK2 | 2.21128724 |
| 13 | NME2 | 2.05825832 |
| 14 | MAP3K12 | 1.97505523 |
| 15 | BMPR1B | 1.96094394 |
| 16 | TAOK3 | 1.91719796 |
| 17 | BUB1 | 1.87421758 |
| 18 | KDR | 1.76294686 |
| 19 | STK38L | 1.76207480 |
| 20 | TGFBR1 | 1.73187414 |
| 21 | PKN2 | 1.68117565 |
| 22 | PBK | 1.66409869 |
| 23 | NEK9 | 1.64614231 |
| 24 | ACVR1B | 1.63900573 |
| 25 | INSRR | 1.61545627 |
| 26 | MAPK11 | 1.56902848 |
| 27 | NME1 | 1.56147481 |
| 28 | ABL2 | 1.55005319 |
| 29 | PIK3CG | 1.52418195 |
| 30 | MST1R | 1.49083093 |
| 31 | WEE1 | 1.47522820 |
| 32 | TGFBR2 | 1.45063625 |
| 33 | TYK2 | 1.44928881 |
| 34 | MAP4K2 | 1.35915219 |
| 35 | NEK1 | 1.35464861 |
| 36 | OXSR1 | 1.33202630 |
| 37 | MAP2K3 | 1.30560815 |
| 38 | TAF1 | 1.29956281 |
| 39 | MUSK | 1.27108090 |
| 40 | MAPKAPK3 | 1.26630449 |
| 41 | STK39 | 1.23120548 |
| 42 | TIE1 | 1.22457781 |
| 43 | PINK1 | 1.20622181 |
| 44 | ZAK | 1.13450293 |
| 45 | MAP2K4 | 1.12741092 |
| 46 | CCNB1 | 1.11935612 |
| 47 | WNK4 | 1.07126962 |
| 48 | ADRBK2 | 1.07069854 |
| 49 | PHKG1 | 1.05606999 |
| 50 | PHKG2 | 1.05606999 |
| 51 | EIF2AK3 | 1.04957251 |
| 52 | LATS1 | 1.03060582 |
| 53 | CDK8 | 1.00594834 |
| 54 | TTK | 0.98772906 |
| 55 | MAP3K11 | 0.97663932 |
| 56 | SRPK1 | 0.94981210 |
| 57 | EIF2AK2 | 0.94048833 |
| 58 | IRAK3 | 0.91071140 |
| 59 | TESK2 | 0.90394841 |
| 60 | MAP3K14 | 0.88618377 |
| 61 | MAPKAPK5 | 0.87808442 |
| 62 | DAPK1 | 0.86328543 |
| 63 | CDK4 | 0.86004532 |
| 64 | BRSK2 | 0.85519065 |
| 65 | PLK3 | 0.84713848 |
| 66 | ERBB3 | 0.84013031 |
| 67 | CSNK1A1L | 0.81619854 |
| 68 | PLK1 | 0.81268259 |
| 69 | CDK7 | 0.79323705 |
| 70 | MAP2K6 | 0.78510517 |
| 71 | TRIM28 | 0.77179232 |
| 72 | TBK1 | 0.76457036 |
| 73 | PRKCI | 0.76156776 |
| 74 | AURKB | 0.75058783 |
| 75 | FRK | 0.74272523 |
| 76 | KIT | 0.73962893 |
| 77 | MAPK4 | 0.72698634 |
| 78 | CDK6 | 0.72694453 |
| 79 | AURKA | 0.72618179 |
| 80 | PLK4 | 0.70991982 |
| 81 | JAK2 | 0.70795602 |
| 82 | WNK3 | 0.70756323 |
| 83 | PRKAA2 | 0.69356867 |
| 84 | FER | 0.68898520 |
| 85 | BMPR2 | 0.68182126 |
| 86 | STK4 | 0.67603806 |
| 87 | MKNK1 | 0.67063088 |
| 88 | TAOK2 | 0.66967675 |
| 89 | ERBB2 | 0.66831110 |
| 90 | PAK3 | 0.66053642 |
| 91 | GRK6 | 0.65786181 |
| 92 | LIMK1 | 0.65516361 |
| 93 | PRKCE | 0.62609743 |
| 94 | PRKD2 | 0.61687249 |
| 95 | SCYL2 | 0.61657037 |
| 96 | TEC | 0.61139116 |
| 97 | CSNK1G2 | 0.60936982 |
| 98 | MYLK | 0.60713749 |
| 99 | MAP3K6 | 0.60549676 |
| 100 | DYRK1B | 0.60166298 |
| 101 | PDK3 | 0.60007220 |
| 102 | PDK4 | 0.60007220 |
| 103 | CDC7 | 0.59366395 |
| 104 | CSNK2A1 | 0.59219158 |
| 105 | MAP3K3 | 0.57059790 |
| 106 | BTK | 0.56913278 |
| 107 | MAP3K10 | 0.56632757 |
| 108 | MKNK2 | 0.55952733 |
| 109 | VRK1 | 0.55912611 |
| 110 | PTK6 | 0.54573802 |
| 111 | PIK3CA | 0.54290332 |
| 112 | MET | 0.53719265 |
| 113 | EPHA2 | 0.53043456 |
| 114 | DYRK3 | 0.51516570 |
| 115 | OBSCN | 0.50830948 |
| 116 | CSF1R | 0.50615387 |
| 117 | RPS6KB2 | 0.50614874 |
| 118 | MAP3K8 | 0.50269707 |
| 119 | CSNK2A2 | 0.50147247 |
| 120 | PIM1 | 0.47102201 |
| 121 | PRKCH | 0.46379651 |
| 122 | ADRBK1 | 0.44300852 |
| 123 | AKT2 | 0.44032162 |
| 124 | STK3 | 0.43566776 |
| 125 | TRPM7 | 0.43539592 |
| 126 | DAPK3 | 0.42410232 |
| 127 | GSK3A | 0.42297873 |
| 128 | IKBKB | 0.41311143 |
| 129 | CSNK1G1 | 0.41248606 |
| 130 | LATS2 | 0.40819688 |
| 131 | GRK1 | 0.40761367 |
| 132 | PASK | 0.39965026 |
| 133 | ATR | 0.39741896 |
| 134 | IKBKE | 0.39349872 |
| 135 | PRKACG | 0.38770260 |
| 136 | AKT3 | 0.38575633 |
| 137 | PIM2 | 0.38073830 |
| 138 | CHEK2 | 0.37866534 |
| 139 | MAP4K1 | 0.36970753 |
| 140 | RPS6KA5 | 0.36785123 |
| 141 | MAP3K5 | 0.35103356 |
| 142 | MAP3K7 | 0.34973630 |
| 143 | CHEK1 | 0.32928852 |
| 144 | CSNK1G3 | 0.32690723 |
| 145 | MAPK12 | 0.32648547 |
| 146 | TLK1 | 0.32302188 |
| 147 | ATM | 0.32116722 |
| 148 | ILK | 0.31714767 |
| 149 | CAMK2G | 0.31683413 |
| 150 | NEK6 | 0.31284555 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.14258308 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.24506115 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.93569533 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.81120843 |
| 5 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.74061124 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.66302970 |
| 7 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.61379240 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.51532560 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.51252468 |
| 10 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.48454850 |
| 11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.45310422 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.40211414 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.27356335 |
| 14 | Peroxisome_Homo sapiens_hsa04146 | 2.15537235 |
| 15 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.09707053 |
| 16 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.08349013 |
| 17 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.07057162 |
| 18 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.96825909 |
| 19 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.93780666 |
| 20 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.91551031 |
| 21 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.90826898 |
| 22 | Histidine metabolism_Homo sapiens_hsa00340 | 1.82027449 |
| 23 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.81157170 |
| 24 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.75018863 |
| 25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.73947912 |
| 26 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.72063460 |
| 27 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.71087689 |
| 28 | Retinol metabolism_Homo sapiens_hsa00830 | 1.70736098 |
| 29 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.69120159 |
| 30 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.65422688 |
| 31 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.62484355 |
| 32 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.59166698 |
| 33 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.58333567 |
| 34 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.51368403 |
| 35 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.50527252 |
| 36 | * Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.50140381 |
| 37 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.46221547 |
| 38 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.45182535 |
| 39 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.42557979 |
| 40 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.42499497 |
| 41 | Alzheimers disease_Homo sapiens_hsa05010 | 1.39317126 |
| 42 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.39284234 |
| 43 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.36238340 |
| 44 | Carbon metabolism_Homo sapiens_hsa01200 | 1.34950770 |
| 45 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.31226418 |
| 46 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.24316485 |
| 47 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.21877324 |
| 48 | Bile secretion_Homo sapiens_hsa04976 | 1.18014437 |
| 49 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.14377370 |
| 50 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.13977566 |
| 51 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.12638907 |
| 52 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.07079140 |
| 53 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.06317435 |
| 54 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.05738473 |
| 55 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.01863409 |
| 56 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.99468265 |
| 57 | Sulfur relay system_Homo sapiens_hsa04122 | 0.99440056 |
| 58 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.97290631 |
| 59 | ABC transporters_Homo sapiens_hsa02010 | 0.96918786 |
| 60 | Asthma_Homo sapiens_hsa05310 | 0.96041639 |
| 61 | Basal transcription factors_Homo sapiens_hsa03022 | 0.93667328 |
| 62 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.92558417 |
| 63 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.91163519 |
| 64 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.86891651 |
| 65 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.83914576 |
| 66 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.82488405 |
| 67 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.81930016 |
| 68 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.78853632 |
| 69 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.77689645 |
| 70 | Lysine degradation_Homo sapiens_hsa00310 | 0.75124861 |
| 71 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.73274520 |
| 72 | Phototransduction_Homo sapiens_hsa04744 | 0.67819122 |
| 73 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.62867047 |
| 74 | Metabolic pathways_Homo sapiens_hsa01100 | 0.62557747 |
| 75 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.61280615 |
| 76 | RNA transport_Homo sapiens_hsa03013 | 0.60998367 |
| 77 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.57571482 |
| 78 | Spliceosome_Homo sapiens_hsa03040 | 0.57335393 |
| 79 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.51817700 |
| 80 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.50769789 |
| 81 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.48057051 |
| 82 | Proteasome_Homo sapiens_hsa03050 | 0.47192123 |
| 83 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.46787603 |
| 84 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.46337423 |
| 85 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.45237790 |
| 86 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.44284715 |
| 87 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.43966334 |
| 88 | Allograft rejection_Homo sapiens_hsa05330 | 0.40708024 |
| 89 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.38019661 |
| 90 | Galactose metabolism_Homo sapiens_hsa00052 | 0.37981302 |
| 91 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.37381519 |
| 92 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.33152471 |
| 93 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.32551786 |
| 94 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.30012846 |
| 95 | Ribosome_Homo sapiens_hsa03010 | 0.24928593 |
| 96 | DNA replication_Homo sapiens_hsa03030 | 0.24906599 |
| 97 | Prion diseases_Homo sapiens_hsa05020 | 0.22817993 |
| 98 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.21210498 |
| 99 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.20356391 |
| 100 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.18404071 |
| 101 | Mismatch repair_Homo sapiens_hsa03430 | 0.16125688 |
| 102 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.16118265 |
| 103 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.08375345 |
| 104 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.08120140 |
| 105 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.07946716 |
| 106 | RNA polymerase_Homo sapiens_hsa03020 | 0.07489033 |
| 107 | Base excision repair_Homo sapiens_hsa03410 | 0.04008829 |
| 108 | Parkinsons disease_Homo sapiens_hsa05012 | 0.03816442 |
| 109 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.03770478 |
| 110 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.03257789 |
| 111 | Purine metabolism_Homo sapiens_hsa00230 | 0.02713205 |
| 112 | Huntingtons disease_Homo sapiens_hsa05016 | -0.1068346 |
| 113 | RNA degradation_Homo sapiens_hsa03018 | -0.1046164 |
| 114 | Non-homologous end-joining_Homo sapiens_hsa03450 | -0.1031708 |
| 115 | Protein export_Homo sapiens_hsa03060 | -0.0938626 |
| 116 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | -0.0872491 |
| 117 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | -0.0232153 |
| 118 | Insulin resistance_Homo sapiens_hsa04931 | -0.0166928 |
| 119 | Homologous recombination_Homo sapiens_hsa03440 | -0.0014885 |

